Translational Pharmacology Core
The Translational Pharmacology Core (TPC) is a multifaceted resource that facilitates clinical and translational pharmacology research among CFAR investigators.
Director: Gene D. Morse, PharmD
- The TPC has been conducting antiretroviral pharmacology research since the beginning of the HIV epidemic and was one of the initial Pharmacology Specialty Laboratories funded at the University of Rochester Clinical Trials Unit when the AIDS Clinical Trials Group (ACTG) was established.
- The Core Director, Gene D. Morse, is a Board Certified Pharmacotherapy Specialist and directs this New York State-approved pharmacology laboratory. The TPC is a training site for numerous national and international faculty, pre-doctoral students, post-doctoral fellows and residents.
- Dr. Morse is the current Director of the ACTG Core Pharmacology Laboratory network and is a member of the Hepatitis Committee and ACTG Executive Committees.
- The TPC is a recognized international leader in HIV Clinical Pharmacology research and training and currently receives NIH funding for the NIAID HIV Clinical Pharmacology Quality Assurance Program, an AIDS Clinical Trials Group Pharmacology Specialty Laboratory and an AIDS International Training and Research Program in Clinical Pharmacology in Zimbabwe from the NIH Fogarty International Center.
- The TPC provides services to CFAR investigators that include: pre-clinical and clinical study design and analysis for pharmacokinetics, pharmacodynamics and pharmacogenomics as well as drug assays, drug interactions, therapeutic drug monitoring and nanopharmacology research.
Read about the Community Advisory Board and Outreach Support
Latest Headlines
Starve a Virus, Feed a Cure?
Feb 2012 - A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online in Nature Immunology. The finding comes from an international team of researchers including scientists from the University of Rochester Medical Center, NYU Langone Medical Center, several institutions in France – and a graduate student who is a political refugee from Africa and is now at work in a Rochester laboratory, intent on helping his people who have been devastated by the HIV epidemic.
Read More
Scientists Explore Whether What Heals the Head Can Also Heal the Heart
A diverse group of scientists – experts in cardiology, neurology, immunology, microbiology and chemistry – are teaming up to study drugs that show promise in the treatment of dementia for the treatment of an equally debilitating disease – heart failure. In this case, the connection between the head and the heart lies in a particular enzyme that they believe plays a role in the development of both conditions.
Read More
